UVXY Stock DD ProShares Trust II 08/04/2014 22:35:25

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
UVXY ProShares Trust II $UVXY Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=UVXY&...mp;yt0=Go!

Last Updated: 08/04/2014 22:35:21

Current Price and Quotes
Last Price 31.54
Previous Close 34.73 Open 34.02
Daily Range 29.95 - 34.94 52wk Range 23.68 - 194.36
Volume 11,277,350 Dividend N/A
Average Vol (3m) 6,182,518 Yield N/A




Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,552 2,215 1,488 2,204
Cost of Revenue - - - -
Gross Profit 1,552 2,215 1,488 2,204
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 34,181 35,095 30,654 14,584
Non-Recurring Items (57) (5) (2) -
Other - - - -
Operating Income (32,572) (32,875) (29,163) (12,379)
Income From Continuing Operations

Add'l Income/Expense Items (879,623) (770,114) (397,060) 339,529
Earnings Before Interest and Tax (912,195) (802,989) (426,223) 327,149
Interest Expense - - - -
Earnings Before Tax (912,195) (802,989) (426,223) 327,149
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (912,195) (802,989) (426,223) 327,149
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (912,195) (802,989) (426,223) 327,149
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (912,195) (802,989) (426,223) 327,149

Recent News

May 30, 2014 DTZ Achieves CIMS and CIMS-Green Building Recertification from ISSA
May 6, 2014 ProShares Resumes Issuance of Creation Units by Eleven Exchange Traded Funds Effective Immediately


UVXY ProShares Trust II Research DD Guide

Stock Message Board http://investorshangout.com/search?q=UVXY&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/UVXY/quote
Stock Chart http://www.otcmarkets.com/stock/UVXY/chart
Company Info http://www.otcmarkets.com/stock/UVXY/company-info
Recent News http://www.otcmarkets.com/stock/UVXY/news
Financials http://www.otcmarkets.com/stock/UVXY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/UVXY/filings
Short Sales http://www.otcmarkets.com/stock/UVXY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/UVXY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/UVXY/research
Summary http://finance.yahoo.com/q?s=UVXY
Historical Prices http://finance.yahoo.com/q/hp?s=UVXY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=UVXY
Basic Chart http://finance.yahoo.com/q/bc?s=UVXY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=UVXY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=UVXY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=UVXY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=UVXY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=UVXY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=UVXY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=UVXY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=UVXY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=UVXY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=UVXY
Balance Sheet http://finance.yahoo.com/q/bs?s=UVXY
Cash Flow http://finance.yahoo.com/q/cf?s=UVXY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/UVXY
Market Watch http://www.marketwatch.com/investing/stock/UVXY
Bloomberg http://www.bloomberg.com/quote/UVXY:US
Morningstar http://quotes.morningstar.com/stock/s?t=UVXY
Bussinessweek http://investing.businessweek.com/research/st...icker=UVXY
Barchart http://www.barchart.com/quotes/stocks/UVXY
OTC Short Report http://otcshortreport.com/index.php?index=UVXY
Investopedia http://www.investopedia.com/markets/stocks/UVXY/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 37

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 34

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing the P/E Ratio of Western Alliance: Insights and Trends

Updated Category News Views 123

Understanding the P/E Ratio of Western Alliance In the current market climate, Western Alliance Inc. (WAL) has seen its share price hit $79.17, reflecting a modest increase of 0.47%. Over the past month, however, the stock has experienced a decrease of 6.61%. Interestingly, despite this recent dip, when we look at the yearly perspective, the stock has climbed by 6.77%...

Continue Reading
Hesai Group Innovates Lidar Technology for Cadillac SUVs

Updated Category News Views 219

Hesai Group Powers Cadillac's VISTIQ with Advanced Lidar Technology Hesai Group, a prominent player in lidar technology, has achieved a significant milestone by partnering with SAIC-GM to integrate its advanced AT series lidar system into Cadillac's new all-electric VISTIQ SUV. This integration represents a breakthrough in automotive design and technology, as it is the...

Continue Reading
Jeffersonville Bancorp Reports Strong Q2 Earnings and Dividend

Updated Category News Views 121

Jeffersonville Bancorp Delivers Impressive Earnings for Q2 Jeffersonville Bancorp, Inc. (OTCQB - JFBC) reported robust second quarter results, showcasing a net income of $3,290,000, equivalent to $0.78 per share. This financial performance indicates a notable increase from the previous year's earnings of $3,031,000, or $0.72 per share, reflecting a significant rise in...

Continue Reading
SAS, NPower Team Up: Disrupting Tech Career Access

Updated Category News Views 12

An Unlikely Alliance Fueling Tech Careers Not every day do you see a big-name data firm strut their stuff in the nonprofit world. SAS has teamed up with NPower to flip the script on tech career access. This isn't just a side project—it's a full-throttle mission to drive hardcore data understanding into communities that have long been left hanging. Right here in Cary,...

Continue Reading
America's Emotional Landscape: Loneliness and Division Exposed

Updated Category News Views 216

Understanding the Impact of Societal Division on Emotional Health Most U.S. adults report feeling isolated, in need of more emotional support Loneliness and a sense of emotional disconnection are increasingly shaping the lifes of individuals in America. Recent findings reveal that a significant majority of U.S. adults feel stressed due to societal division. This insight...

Continue Reading